(-)-Gossypol containing hen sera and a myosin (-)-gossypol conjugate reduces the proliferation of MCF-7 cells

Anticancer Research

Volumn 30, Issue 2, 2010, Pages 439-444

  Reddish, J M ^a   Ye, W ^a   Lin, Y C ^a,b   Wick, M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

( ) Gossypol; Anticancer; Breast cancer; Gossypolmyosin; MCF 7 cells

Indexed keywords

GOSSYPOL; LACTATE DEHYDROGENASE; MYOSIN;

ANIMAL EXPERIMENT; ANTINEOPLASTIC ACTIVITY; ARTICLE; BODY MASS; BREAST CANCER; CELL PROLIFERATION; CELL STRAIN MCF 7; CONJUGATE; CONTROLLED STUDY; DRUG PROTEIN BINDING; EGG PRODUCTION; HEN; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SERUM CHARACTERISTICS;

ANIMAL FEED; ANIMAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ANIMALS; BREAST NEOPLASMS; CELL PROLIFERATION; CHICKENS; CONTRACEPTIVE AGENTS, MALE; COTTONSEED OIL; FEMALE; GOSSYPOL; HUMANS; L-LACTATE DEHYDROGENASE; LIVER FUNCTION TESTS; MYOSINS; TUMOR CELLS, CULTURED;

EID: 77950523906     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Boatner C, Castillon L, Hall C and Neely J: Gossypol and gossypurpurin in cottonseed of different varieties of G. barbadense and G. hirsutum, and variation of the pigments during storage of the seed. J Am Oil Chem Soc 26(1): 19-25, 1949.
2. Cherian G, Wolfe FW and Sim JS: Dietary oils with added tocopherols: effects on egg or tissue tocopherols, fatty acids, and oxidative stability. Poult Sci 75(3): 423-431, 1996.
3. Cherian G, Holsonbake TB, Goeger MP and Bildfell R: Dietary CLA alters yolk and tissue FA composition and hepatic histopathology of laying hens. Lipids 37(8): 751-757, 2002.
4. Cherian G, Traber MG, Goeger MP and Leonard SW: Conjugated linoleic acid and fish oil in laying hen diets: effects on egg fatty acids, thiobarbituric acid reactive substances, and tocopherols during storage. Poult Sci 86(5): 953-958, 2007.
5. Food and Drug Administration. Food Drug Cosmetic Law 56, 518.94, 172.894, 1974.
6. Band V, Hoffer AP, Band H, Rhinehardt AE, Knapp RC, Matlin SA et al: Antiproliferative effect of gossypol and its optical isomers on human reproductive cancer cell lines. Gynecol Oncol 32(3): 273-277, 1989.
7. 31P magnetic resonance spectroscopy, and in vitro antimitochondrial tumor toxicity with gossypol and rhodamine-123. J Clin Invest 79(2): 517-523, 1987.
8. Benz C, Keniry M and Goldberg H: Selective toxicity of gossypol against epithelial tumors and its detection by magnetic resonance spectroscopy. Contraception 37(3): 221-228, 1988.
9. Benz CC, Keniry MA, Ford JM, Townsend AJ, Cox FW, Palayoor S et al: Biochemical correlates of the antitumor and antimitochondrial properties of gossypol enantiomers. Mol Pharmacol 37(6): 840-847, 1990.
10. Coyle T, Levante S, Shetler M and Winfield J: In vitro and in vivo cytotoxicity of gossypol against central nervous system tumor cell lines. J Neurooncol 19(7): 25-35, 1994.
11. 31P nuclear magnetic resonance and toxicity studies. Cancer Res 50(21): 6936-6943, 1990.
12. Liang XS, Rogers AJ, Webber CL, Ormsby TJ, Tiritan ME, Matlin SA et al: Developing gossypol derivatives with enhanced antitumor activity. Invest New Drugs 13(3): 181-186, 1995.
13. Thomas M, von Hagen V, Moustafa Y, Montmasson MP and Monet JD: Effects of gossypol on the cell cycle phases in T-47D human breast cancer cells. Anticancer Res 11(4): 1469-1475, 1991.
14. Tuszynski GP and Cossu G: Differential cytotoxic effect of gossypol on human melanoma, colon carcinoma, and other tissue culture cell lines. Cancer Res 44(2): 768-771, 1984.
15. Wang Y and Rao PN: Effect of gossypol on DNA synthesis and cell cycle progression of mammalian cells in vitro. Cancer Res 44(1): 35-38, 1984.
16. Wu YW, Chik CL and Knazek RA: An in vitro and in vivo study of antitumor effects of gossypol on human SW-13 adrenocortical carcinoma. Cancer Res 49(14): 3754-3758, 1989.
17. Hu YF, Chang CJ, Brueggemeier RW and Lin YC: Gossypol inhibits basal and estrogen-stimulated DNA synthesis in human breast carcinoma cells. Life Sciences 53(25): PL433-438, 1993.
18. Gilbert NE, O'Reilly JE, Chang CJ, Lin YC and Brueggemeier RW: Antiproliferative activity of gossypol and gossypolone on human breast cancer cells. Life Sci 57(1): 61-67, 1995.
19. Shidaifat F, Canatan H, Kulp SK, Sugimoto Y, Chang WY, Zhang Y et al: Inhibition of human prostate cancer cells growth by gossypol is associated with stimulation of transforming growth factor-beta. Cancer Lett 107(1): 37-44, 1996.
20. 1 phase of the cell cycle. Anticancer Res 17(2A): 1003-1009, 1997.
21. Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW and Lin YC: Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats. Res Commun Chem Pathol Pharmacol 79(3): 293-312, 1993.
22. Ligueros M, Jeoung D, Tang B, Hochhauser D, Reidenberg MM and Sonenberg M: Gossypol inhibition of mitosis, cyclin D1 and Rb protein in human mammary cancer cells and cyclin-D1 transfected human fibrosarcoma cells. Br J Cancer 76(1): 21-28, 1997.
23. Joseph AE, Matlin SA and Knox P: Cytotoxicity of enantiomers of gossypol. Br J Cancer 54(3): 511-513, 1986.
24. Shelley MD, Hartley L, Groundwater PW and Fish RG: Structure-activity studies on gossypol in tumor cell lines. Anticancer Drugs 11(3): 209-216, 2000.
25. Zhang Y, Wang Y, Li C, Zhou J, Zhang D and Han M: Estrogen and progestin cytosol receptor concentrations in patients with endometriosis and their changes after gossypol therapy. Chin Med J (Engl) 109(10): 814-816, 1996.
26. Margossian SS and Lowey S: Preparation of myosin and its subfragments from rabbit skeletal muscle. Methods Enzymol 85(Pt B): 55-71, 1982.
27. Laemmli UK: Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227(5259): 680-685, 1970.
28. Moore LA, Arrizubieta MJ, Tidyman WE, Herman LA and Bandman E: Analysis of the chicken fast myosin heavy chain family. Localization of isoform-specific antibody epitopes and regions of divergence. J Mol Biol 225(4): 1143-1151, 1992.
29. SAS version 9.1.3, SAS Institute; Cary, NC, 2009.
30. Lordelo MM, Calhoun MC, Dale NM, Dowd MK and Davis AJ: Relative toxicity of gossypol enantiomers in laying and broiler breeder hens. Poult Sci 86(3): 582-590, 2007.
31. Akira A, Ohmura H, Uzumcu M, Araki T and Lin YC: Gossypol inhibits aromatase activity in cultured porcine granulosa cells. Theriogenology 41(7): 1489-1497, 1994.
32. Hu YF, Chang CJ, Brueggemeier RW and Lin YC: Presence of antitumor activities in the milk collected from gossypol-treated dairy cows. Cancer Lett 87(1): 17-23, 1994.
33. 3H-gossypol to neonatal rats via milk of nursing dams. Life Sci 51(21): 1657-1665, 1992.
34. Lin YC, Gu Y, Brueggemeier RW and Rikihisa Y: Binding of - gossypol in organelles of cultured bovine luteal cells. Life Sci 50(6): 443-447, 1992.
35. Howell A: Adjuvant aromatase inhibitors for breast cancer. Lancet 366(9484): 431-433, 2005.
36. Thurlimann B, Keshaviah A, Coates AS, Mouridsen H, Mauriac L, Forbes JF et al: A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer. N Engl J Med 353(26): 2747-2757, 2005.
37. Coates AS, Keshaviah A, Thurlimann B, Mouridsen H, Mauriac L, Forbes JF et al: Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98. J Clin Oncol 25(5): 486-492, 2007.
38. Rose C: Increasing protection after tamoxifen: insights from the extended adjuvant aromatase inhibitor trials. J Cancer Res Clin Oncol 134(1): 7-17, 2008.
39. Lin YC, Nuber DC, Gu Y, Gutler G, Hinchcliff KW and Haibel G: Pharmacokinetics of gossypol in mid-lactation brown Swiss dairy cows. Vet. R. Commun. 15: 379-385, 1991.
40. Lin YC and Gu Y: Suppresion of cAMP production in cultured bovine luteal cells by serum obtained from gossypol-treated nursing dams. Biol. Reprod. Suppl1 40: 313A, 1989.